IL6 and depressive symptom measurement: Increased peripheral inflammatory markers (e.g., Interleukin-6 (IL-6), C-reactive protein (CRP), tumour necrosis factor alpha (TNFα)) are associated with worse cognitive performance even in the absence of disease [6], consistent with a contribution of inflammation to the cognitive decline seen in depression [3].